ABBOTINDIA:NSE Abbott India Limited

INR 27,945.05 540.90 1.973789
Icon

Abbott India Limited (ABBOTINDIA:NSE) Stock Analysis and Price Targets

COMMON STOCK | Drug Manufacturers - General | NSE
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Bullish

Stock Target Advisor
Analysis
stockTargetAdvisor

Strong Buy

Average User
Rating

INR 27,945.05

+540.90 (+1.97)%

INR 589.45B

0.02M

N/A

INR 20500.00 (-26.64%)

Icon

ABBOTINDIA:NSE

Abbott India Limited (INR)
COMMON STOCK | NSE
INR 27,945.05
0.00 0
Take a Tour
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Bullish

Stock Target Advisor
Analysis
stockTargetAdvisor

Strong Buy

Average User
Rating

INR 589.45B

INR 20500.00 (-26.64%)

INR 27,945.05

Abbott India Limited (ABBOTINDIA:NSE) Stock Forecast

INR 28,500.00
(+1.99%)

Based on the Abbott India Limited stock forecast from 1 analysts, the average analyst target price for Abbott India Limited is INR 28,500.00 over the next 12 months. Abbott India Limited’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Abbott India Limited is Bullish , which is based on 10 positive signals and 3 negative signals. At the last closing, Abbott India Limited’s stock price was INR 27,945.05. Abbott India Limited’s stock price has changed by -2.28% over the past week, +4.08% over the past month and +20.54% over the last year.

No recent analyst target price found for Abbott India Limited
No recent average analyst rating found for Abbott India Limited

Company Overview Abbott India Limited

Abbott India Limited, together with its subsidiaries, operates as a pharmaceutical company in India. The company offers pharmaceutical products for gastroenterology, women's health, metabolic, central nervous system, vaccines, and multispecialty, including insomnia, vitamin D def...Read More

https://www.abbott.co.in

Godrej BKC, Mumbai, India, 400051

3,814

March

INR

India

Adjusted Closing Price for Abbott India Limited (ABBOTINDIA:NSE)

Loading...

Unadjusted Closing Price for Abbott India Limited (ABBOTINDIA:NSE)

Loading...

Share Trading Volume for Abbott India Limited Shares

Loading...

Compare Performance of Abbott India Limited Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for ABBOTINDIA:NSE

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To Abbott India Limited (Sector: Drug Manufacturers - General )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
CIPLA:NSE
Cipla Limited -3.65 (-0.24%) INR1,213.15B 29.48 17.05

ETFs Containing ABBOTINDIA

Symbol Name ABBOTINDIA's Weight Expense Ratio Price(Change) Market Cap
no data

Frequently Asked Questions About Abbott India Limited (ABBOTINDIA:NSE) Stock

Based on ratings from 1 analysts Abbott India Limited's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Bullish . The stock has 1 buy, sell and hold ratings.

ABBOTINDIA:NSE stock's dividend yield is 1.50%. Our analysis grades ABBOTINDIA:NSE stock's dividend yield at C. This means that ABBOTINDIA:NSE stock's dividend yield is above 75% of the stocks in the Drug Manufacturers - General sector in the NSE exchange. Based on this ABBOTINDIA:NSE may be a average dividend stock for its sector.

Based on targets from 1 analysts, the average taret price for ABBOTINDIA:NSE is INR 28,500.00 over the next 12 months. The maximum analyst target price is INR 28500 while the minimum anlayst target price is INR 28500.

ABBOTINDIA:NSE stock's Price/Earning ratio is 49.13. Our analysis grades ABBOTINDIA:NSE stock's Price / Earning ratio at F. This means that ABBOTINDIA:NSE stock's Price/Earning ratio is above 82% of the stocks in the Drug Manufacturers - General sector in the NSE exchange. Based on this ABBOTINDIA:NSE may be a overvalued for its sector.

The last closing price of ABBOTINDIA:NSE's stock was INR 27,945.05.

The most recent market capitalization for ABBOTINDIA:NSE is INR 589.45B.

Based on targets from 1 analysts, the average taret price for ABBOTINDIA:NSE is projected at INR 28,500.00 over the next 12 months. This means that ABBOTINDIA:NSE's stock price may go up by +1.99% over the next 12 months.

We can't find any ETFs which contains Abbott India Limited's stock.

As per our most recent records Abbott India Limited has 3,814 Employees.

Abbott India Limited's registered address is Godrej BKC, Mumbai, India, 400051. You can get more information about it from Abbott India Limited's website at https://www.abbott.co.in.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...